Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
- Peter Lynch
Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The company was founded in 2016 and is based in London, the United Kingdom.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2023-01-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 1,272 | $26.89 | $34,204 | No |
| 2023-01-18 | Merendino Lauren | Chief Commercial Officer | Sell | 2,008 | $26.89 | $53,995 | No |
| 2023-01-18 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 1,109 | $26.89 | $29,821 | No |
| 2023-01-04 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2,251 | $26.90 | $60,552 | No |
| 2023-01-04 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 2,779 | $26.90 | $74,755 | No |
| 2022-12-16 | Mehra Uneek | Principal Financial Officer | Sell | 2,241 | $26.75 | $59,947 | No |
| 2022-10-18 | Merendino Lauren | Chief Commercial Officer | Sell | 1,703 | $25.20 | $42,916 | No |
| 2022-10-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 1,933 | $25.20 | $48,712 | No |
| 2022-10-18 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 1,604 | $25.20 | $40,421 | No |
| 2022-10-04 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2,738 | $24.40 | $66,807 | No |
| 2022-09-16 | Mehra Uneek | Principal Financial Officer | Sell | 9,243 | $18.86 | $174,323 | No |
| 2022-08-15 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 31,214 | $18.23 | $569,031 | No |
| 2022-07-18 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 1,935 | $12.87 | $24,903 | No |
| 2022-07-18 | Merendino Lauren | Chief Commercial Officer | Sell | 1,704 | $12.87 | $21,930 | No |
| 2022-07-18 | Marek David C | Principal Executive Officer | Sell | 11,164 | $12.87 | $143,681 | No |
| 2022-07-06 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 3,702 | $13.40 | $49,607 | No |
| 2022-04-19 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 8,002 | $10.45 | $83,621 | No |
| 2022-04-19 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 4,632 | $10.45 | $48,404 | No |
| 2022-04-19 | Merendino Lauren | Chief Commercial Officer | Sell | 7,049 | $10.45 | $73,662 | No |
| 2022-04-19 | Marek David C | Principal Executive Officer | Sell | 24,594 | $10.45 | $257,007 | No |
| 2022-04-05 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 2,436 | $13.78 | $33,568 | No |
| 2022-03-01 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 1,362 | $13.35 | $18,183 | No |
| 2022-01-19 | Marek David C | Principal Executive Officer | Sell | 19,882 | $14.68 | $291,868 | No |
| 2022-01-04 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 4,475 | $16.27 | $72,808 | No |
| 2021-11-29 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 1,978 | $19.30 | $38,175 | No |
| 2021-11-04 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 3,800 | $24.02 | $91,262 | Yes |
| 2021-10-05 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 2,738 | $21.62 | $59,196 | No |
| 2021-10-05 | Lang Matthew | General Counsel & Corp. Secy. | Sell | 6,671 | $21.62 | $144,227 | No |
| 2021-09-27 | Arjona Ferreira Juan Camilo | Chief Medical Officer | Sell | 7,000 | $24.32 | $170,240 | Yes |
| 2021-09-27 | Sumitomo Chemical Co., Ltd. | 10%-Owner | Buy | 84,000 | $23.87 | $2,004,937 | No |
Insider Smart
Insider Smart